Learn More
Invitrogen™ c-Met Recombinant Rabbit Monoclonal Antibody (6O7V1)
Rabbit Recombinant Monoclonal Antibody
158.00 CHF - 393.00 CHF
Spezifikation
Antigen | c-Met |
---|---|
Klon | 6O7V1 |
Konzentration | 0.95 mg/mL |
Inhalt und Lagerung | -20°C, Avoid Freeze/Thaw Cycles |
Anwendungen | ELISA, Western Blot, Immunocytochemistry |
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | ||||||
30284487
|
Invitrogen™
MA557867 |
20 μL |
158.00 CHF
20 Mikroliter |
Verfügbar ab: 16-06-2025
Loggen Sie sich ein, um den Lagerbestand zu sehen |
Sie haben bereits ein Konto? Melden Sie sich an um den Preis und die Verfügbarkeit zu sehen. Neu hier? Registrieren Sie sich noch heute bei uns! |
|||||
30282559
|
Invitrogen™
MA557868 |
100 μL |
393.00 CHF
100 Mikroliter |
Verfügbar ab: 16-06-2025
Loggen Sie sich ein, um den Lagerbestand zu sehen |
Sie haben bereits ein Konto? Melden Sie sich an um den Preis und die Verfügbarkeit zu sehen. Neu hier? Registrieren Sie sich noch heute bei uns! |
|||||
Beschreibung
Immunogen sequence: QIKDLGSELV RYDARVHTPH LDRLVSARSV SPTTEMVSNE SVDYRATFPE DQFPNSSQNG SCRQVQYPLT DMSPILTSGD SDISSPLLQN TVHIDLSALN PELVQAVQHV VIGPSSLIVH FNEVIGRGHF GCVYHGTLLD NDGKKIHCAV KSLNRITDIG EVSQFLTEGI IMKDFSHPNV LSLLGICLRS EGSPLVVLPY MKHGDLRNFI RNETHNPTVK DLIGFGLQVA KGMKYLASKK FVHRDLAARN CMLDEKFTVK VADFGLARDM YDKEYYSVHN KTGAKLPVKW MALESLQTQK FT.
MET (cMET) is a receptor-like tyrosine kinase whose dysregulation has been linked to many types of human malignancies. After activation of the ligand, MET interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, and STAT3. There interactions lead to the activation of signaling cascades including RAS-ERK, PI3, kinase-AKT, and PLCgamma-PKC. MET plays a role in embryonic development including gastrulation, development of muscles and neurons, angiogenesis, and kidney formation. It also plays a role in adults including wound healing, organ regeneration, and tissue remodeling. MET has been linked to cancers including gastric, renal, and breast; therefore, making it a target for cancer therapeutics and diagnostic testing.Spezifikation
c-Met | |
0.95 mg/mL | |
ELISA, Western Blot, Immunocytochemistry | |
Unconjugated | |
Rabbit | |
RUO | |
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3 | |
P08581, P16056 | |
17295, 4233 | |
Recombinant fusion protein containing a sequence corresponding to amino acids 960-1161 of human MET (NP_000236.2). | |
Antibody |
6O7V1 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Recombinant Monoclonal | |
Liquid | |
IgG | |
Human, Mouse | |
MET | |
AI838057; AUTS9; bHLHe59; CG1705; CG1705-PA; CG1705-PB; cmet; c-met; c-met proto-oncogene; c-Met receptor tyrosine kinase; c-Met/HGF receptor; D249; DFNB97; Dmel\CG1705; Dmel_CG1705; DmMet; EC 2.7.10.1; Hepatocyte growth factor receptor; HGF; HGF receptor; HGF receptor c-Met; HGF/SF receptor; HGFR; HGF-SF receptor; juvenile hormone resistance; met; met proto-oncogene; met proto-oncogene (hepatocyte growth factor receptor); met proto-oncogene tyrosine kinase; MET proto-oncogene, receptor tyrosine kinase; Met/Met1; Met; protein tyrosin kinase; methoprene tolerant; Methoprene-tolerant; Methoprene-tolerant protein; Met-PA; Met-PB; Mett; oncogene MET; Par4; Proto-oncogene c-Met; RCCP2; resistance (1) juvenile H; resistance to juvenile hormone; Rst(1)JH; sc MET; scatter factor receptor; SF receptor; soluble c met; tyrosine-protein kinase Met | |
MET | |
Primary | |
Protein A |
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.